Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BOSTON SCIENTIFIC CORPORATION

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

LithoVue Elite Registry

Withdrawn

Conditions: Urolithiasis
Kidney Stone

Interventions: Device: LithoVue Elite System

First Posted Date: 2022-01-21

Last Posted Date: 2023-12-18

Lead Sponsor: Boston Scientific Corporation

Registration Number: NCT05201456

TheraSphere With Durvalumab and Tremelimumab for HCC

Phase 2

Recruiting

Conditions: Hepatocellular Carcinoma

Interventions: Device: TheraSphere Y-90 glass microsphere therapy
Drug: Durvalumab (Imfinzi) immunotherapy
Drug: Tremelimumab immunotherapy

First Posted Date: 2021-10-01

Last Posted Date: 2025-06-27

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 100

Registration Number: NCT05063565

Locations: 🇫🇷
Chu Henri Mondor, Creteil, France
🇫🇷
Chru De Lille, Lille, France
🇫🇷
Hopital Paul Brousse, Villejuif Cedex, France

and more 32 locations

Flexiva Pulse Registry

Completed

Conditions: Urinary Calculi
Benign Prostatic Hyperplasia

Interventions: Device: Flexiva Pulse High Power Single-Use Laser Fibers

First Posted Date: 2021-08-31

Last Posted Date: 2025-05-29

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 201

Registration Number: NCT05027971

Locations: 🇺🇸
Mayo Clinic Pheonix, Phoenix, Arizona, United States
🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸
AdventHealth Orlando, Orlando, Florida, United States

and more 1 locations

MANDARIN (S6371)

Phase 3

Active, not recruiting

Conditions: Inoperable Hepatocellular Carcinoma

Interventions: Procedure: conventional Transarterial Chemoembolization(cTACE)
Combination Product: TheraSphere™ Yttrium-90 Glass Microspheres

First Posted Date: 2021-08-23

Last Posted Date: 2025-06-17

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 92

Registration Number: NCT05016245

Locations: 🇨🇳
Zhongda Hospital Southeast University, Nanjing, Jiangsu, China

Step and Walking Pattern From Cardiac Monitor Study

Terminated

Conditions: Heart Failure NYHA Class II
Heart Failure NYHA Class III
Insertable Cardiac Monitor

Interventions: Device: Wearable Cardiac Monitor

First Posted Date: 2021-07-22

Last Posted Date: 2023-12-13

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 40

Registration Number: NCT04971993

Locations: 🇺🇸
CentraCare Heart and Vascular Clinic, Saint Cloud, Minnesota, United States

Study to Evaluate Automated Intensity Management in Patients Undergoing a BSC SCS Temporary Trial

Not Applicable

Completed

Conditions: Pain, Back
Pain, Neuropathic
Chronic Pain
Intractable Pain
Low Back Pain

Interventions: Device: Spinal Cord Stimulation

First Posted Date: 2021-06-02

Last Posted Date: 2024-12-06

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 21

Registration Number: NCT04909593

Locations: 🇺🇸
PCPMG Clinical Research Unit, LLC, Greenville, South Carolina, United States

Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy

Not Applicable

Active, not recruiting

Conditions: Prostate Cancer

Interventions: Device: SpaceOAR Vue System

First Posted Date: 2021-05-27

Last Posted Date: 2025-06-29

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 500

Registration Number: NCT04905069

Locations: 🇺🇸
GenesisCare USA, Troy, Michigan, United States
🇺🇸
Florida Urology Partners, LLC, Tampa, Florida, United States
🇺🇸
Kansas University Medical Center, Kansas City, Kansas, United States

and more 25 locations

Clinical Outcomes of IVUS-guided Stenting Using the Boston Scientific Vici® Venous Stent System in Treating Patients With Chronic Non-malignant Iliofemoral Vein Obstruction

Not Applicable

Withdrawn

Conditions: Chronic Venous Disorder
Systemic Vein Outflow of Iliofemoral Vein
Venous Outflow Obstruction

Interventions: Device: Boston Scientific Vici® Venous Stent System
Device: Boston Scientific Opticross 35 Peripheral Imaging Catheter (OC35 catheter)

First Posted Date: 2021-04-23

Last Posted Date: 2021-11-01

Lead Sponsor: Boston Scientific Corporation

Registration Number: NCT04856592

REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men

Not Applicable

Active, not recruiting

Conditions: Benign Prostatic Hyperplasia (BPH)

Interventions: Device: REZŪM
Drug: alpha blocker and 5-alpha reductase inhibitor

First Posted Date: 2021-04-09

Last Posted Date: 2025-06-29

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 154

Registration Number: NCT04838769

Locations: 🇦🇺
Epworth Healthcare, Melbourne, Australia
🇦🇺
Australian Clinical Trials, Wahroonga, Australia
🇫🇷
Centre Hospitalier du Pays d'Aix, Aix-en-Provence, France

and more 18 locations

BoStOn SCientific Rhythm MAnagemenT REgiStry (SOCRATES)

Recruiting

Conditions: Cardiac Disease

Interventions: Device: Implant
Procedure: Electrophysiologic procedure

First Posted Date: 2021-04-01

Last Posted Date: 2025-06-04

Lead Sponsor: Boston Scientific Corporation

Target Recruit Count: 12500

Registration Number: NCT04823663

Locations: 🇧🇪
Universitair Ziekenhuis Brussel, Jette, Belgium
🇧🇪
CHU UCL Namur - Site Godinne, Yvoir, Belgium
🇨🇦
Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Quebec City, Quebec, Canada

and more 21 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy